Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Marks

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncogene|February 5, 2013
Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studiesY Cao, J W Marks, Z Liu, et al.
The American Journal of Gastroenterology|February 1, 1978
Gallstone dissolution by chenodeoxycholic acid and phenobarbitalJ W Marks, J H Sherman, G G Bonorris, et al.
Gastroenterology|August 1, 1984
Cyclic nucleotides and glycoproteins during formation of cholesterol gallstones in prairie dogsR A Zak, P G Frenkiel, J W Marks, et al.
American Heart Journal|August 1, 1987
Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motilityA W Hamer, D E Tanasescu, J W Marks, et al.
Surgery|July 1, 1981
Treatment of choledocholithiasis with oral chenodeoxycholic acidS O Sue, M Taub, B J Pearlman, et al.
The American Journal of Digestive Diseases|October 1, 1977
Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstonesJ W Marks, G G Bonorris, A Chung, et al.
Gastroenterology|October 1, 1979
Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster modelB J Pearlman, G G Bonorris, M J Phillips, et al.
The New England Journal of Medicine|December 15, 1988
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weightP H Broomfield, R Chopra, R C Sheinbaum, et al.
The American Journal of Digestive Diseases|December 1, 1977
Gallstone prevalence and biliary lipid composition in inflammatory bowel diseaseJ W Marks, D R Conley, T L Capretta, et al.
The Journal of Clinical Investigation|November 1, 1981
Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstonesJ W Marks, S O Sue, B J Pearlman, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncogene|February 5, 2013
Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studiesY Cao, J W Marks, Z Liu, et al.
The American Journal of Gastroenterology|February 1, 1978
Gallstone dissolution by chenodeoxycholic acid and phenobarbitalJ W Marks, J H Sherman, G G Bonorris, et al.
Gastroenterology|August 1, 1984
Cyclic nucleotides and glycoproteins during formation of cholesterol gallstones in prairie dogsR A Zak, P G Frenkiel, J W Marks, et al.
American Heart Journal|August 1, 1987
Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motilityA W Hamer, D E Tanasescu, J W Marks, et al.
Surgery|July 1, 1981
Treatment of choledocholithiasis with oral chenodeoxycholic acidS O Sue, M Taub, B J Pearlman, et al.
The American Journal of Digestive Diseases|October 1, 1977
Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstonesJ W Marks, G G Bonorris, A Chung, et al.
Gastroenterology|October 1, 1979
Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster modelB J Pearlman, G G Bonorris, M J Phillips, et al.
The New England Journal of Medicine|December 15, 1988
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weightP H Broomfield, R Chopra, R C Sheinbaum, et al.
The American Journal of Digestive Diseases|December 1, 1977
Gallstone prevalence and biliary lipid composition in inflammatory bowel diseaseJ W Marks, D R Conley, T L Capretta, et al.
The Journal of Clinical Investigation|November 1, 1981
Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstonesJ W Marks, S O Sue, B J Pearlman, et al.
Pageof 5